[ Price : $8.95]
FDA accepts for review a Takeda and H. Lundbeck NDA for Brintellix for treating major depressive disorder in adult patients.[ Price : $8.95]
FDA releases discussion points on managing drug teratogenic risk for a rescheduled meeting of the Drug Safety and Risk Management ...[ Price : $8.95]
CDER Office of New Drugs director John Jenkins says his staff are worried about the outcomes from the addition of late-cycle meeti...[ Price : $8.95]
FDA approves a Sucampo Pharmaceuticals supplemental NDA for Rescula 0.15% for lowering intraocular pressure in patients with open-...[ Price : $8.95]
FDA releases the FDA-483 containing 14 inspection observations issued after an April inspection at Celltex Therapeutics.[ Price : $8.95]
Federal Register Notice: FDA submits a proposed collection of information to the Office of Management and Budget on a guidance on ...[ Price : $8.95]
Federal Register Notice: FDA debars Susan F. Knott for two years from providing services to any person with an approved or pending...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites GC America, The Judge Rotenberg Educational Center, MedArt A/S, Parks Medical El...